![2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/f9f18a29-b960-44ca-ac4a-288f538d8312/cir.0000000000000923.tab45.gif)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation
![Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease - The British Journal of Cardiology Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2015/12/Screen-shot-2015-12-15-at-15.35.11.png)
Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease - The British Journal of Cardiology
![PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial](https://www.researchgate.net/profile/Ferdinando-Carlo-Sasso/publication/45090126/figure/fig1/AS:667199467446274@1536084157191/figure-fig1_Q320.jpg)
PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial
![Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527320307774-ga1.jpg)
Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect
![Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12055-019-00789-z/MediaObjects/12055_2019_789_Fig3_HTML.png)
Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink
![Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. - Abstract - Europe PMC Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3699194/bin/nihms482039f1.jpg)
Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. - Abstract - Europe PMC
![Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/d82b7871-4be0-4967-90ba-5c1cfd083051/28ga01.jpeg)
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
![Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | SpringerLink Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40268-018-0249-5/MediaObjects/40268_2018_249_Fig1_HTML.png)
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | SpringerLink
![Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter](https://pbs.twimg.com/media/DA-poORU0AMUX-X.jpg)
Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter
CorConsult Rx - #Repost from @ambcarerx ・・・ Warfarin review! INR goals for most warfarin indications are 2-3, except unless patient has a mechanical mitral valve replacement, in which the INR goal would
![Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York](https://www.mountsinai.org/files/MSHealth/Assets/Global/Newsroom/2021/MSHS-Newsroom-StudyDesign-2col-770x420.jpg)